“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P1.03 Comparison of hemoglobin on RapidPoint 500 blood gas analyser (Siemens) to XE-5000 cell counter (Sysmex)

€2.42

SKU: product-article-19492 Category: General

Description

Description

P1.03 Comparison of hemoglobin on RapidPoint 500 blood gas analyser (Siemens) to XE-5000 cell counter (Sysmex)

Top

Article: P1.03 Comparison of hemoglobin on RapidPoint 500 blood gas analyser (Siemens) to XE-5000 cell counter (Sysmex)

Description

Related products

Article: Highlights in digestive oncology

Article: Highlights in respiratory oncology

Article: Highlights in breast cancer

Article: Highlights in breast cancer